Literature DB >> 2566000

Relation between immunocytochemical estimation of oestrogen receptor in elderly patients with primary breast cancer and response to tamoxifen.

D J Gaskell1, R A Hawkins, K Sangsterl, U Chetty, A P Forrest.   

Abstract

The relation between oestrogen receptor status of primary breast cancer as determined immuncytochemically on fine-needle aspirates and the response to tamoxifen therapy has been assessed in 52 patients. The proportion of cells staining correlated well with the likelihood of response, which emphasises the importance of tumour heterogeneity.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2566000     DOI： 10.1016/s0140-6736(89)92445-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  17 in total

1.  Treatment of elderly patients with breast cancer.

Authors:  J M Dixon
Journal:  BMJ       Date:  1992-04-18

2.  Primary treatment in breast cancer.

Authors:  A P Forrest; E D Anderson; U Chetty
Journal:  BMJ       Date:  1991-03-09

3.  Treating elderly patients with breast cancer.

Authors:  K Dookeran; A Stotter; R Windle; R Walker
Journal:  BMJ       Date:  1992-05-23

4.  A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group.

Authors:  P J van Diest; P van Dam; S C Henzen-Logmans; E Berns; M E van der Burg; J Green; I Vergote
Journal:  J Clin Pathol       Date:  1997-10       Impact factor: 3.411

Review 5.  The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast.

Authors:  Zsolt Hodi; Jayeta Chakrabarti; Andrew H S Lee; John E Ronan; Christopher W Elston; Kwok Leung Cheung; John F R Robertson; Ian O Ellis
Journal:  J Clin Pathol       Date:  2006-05-26       Impact factor: 3.411

Review 6.  Neoadjuvant Trials in ER+ Breast Cancer: A Tool for Acceleration of Drug Development and Discovery.

Authors:  Angel L Guerrero-Zotano; Carlos L Arteaga
Journal:  Cancer Discov       Date:  2017-05-11       Impact factor: 39.397

7.  Cellular effects of tamoxifen in primary breast cancer.

Authors:  J F Robertson; I O Ellis; R I Nicholson; A Robins; J Bell; R W Blamey
Journal:  Breast Cancer Res Treat       Date:  1992-01       Impact factor: 4.872

8.  Tamoxifen as the primary treatment in elderly patients with breast cancer.

Authors:  S B Hooper; A D K Hill; S Kennedy; B Dijkstra; L M Kelly; E W M McDermott; N O'Higgins
Journal:  Ir J Med Sci       Date:  2002 Jan-Mar       Impact factor: 1.568

9.  Low concentrations of the soy phytoestrogen genistein induce proteinase inhibitor 9 and block killing of breast cancer cells by immune cells.

Authors:  Xinguo Jiang; Nicole M Patterson; Yan Ling; Jianwei Xie; William G Helferich; David J Shapiro
Journal:  Endocrinology       Date:  2008-07-31       Impact factor: 4.736

10.  ERICA predicts response to tamoxifen in elderly women with breast cancer.

Authors:  N Davies; G Moir; R Carpenter; A Cuthbert; A Herbert; G T Royle; I Taylor
Journal:  Ann R Coll Surg Engl       Date:  1991-11       Impact factor: 1.891
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.